Errichetti, E., Wolf, P., Khattri, S., Gorecki, P., Miller, M., Jiang, J., … Kirby, B. (2024). Patients with Persistent Mild Psoriasis after Treatment with Ustekinumab Achieved Greater Improvements in Skin Clearance and Patient-reported Outcomes after Switching to Guselkumab in the Phase 3 NAVIGATE Trial. Acta Dermato-Venereologica, 104, adv41053. https://doi.org/10.2340/actadv.v104.41053